drugset / Trial / NCT03270553

A Study to Assess the Effect of Plazomicin on the Pharmacokinetics of Metformin

NCT03270553

Phase 1 Completed 16 enrolled Achaogen, Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

This is a single-center, Phase 1, open label, randomized, two-sequence, two-period, crossover study to evaluate the drug-drug interaction potential between plazomicin and metformin in healthy subjects.

Timeline

Start
2017-08-31
Primary completion
2017-10-07
Completion
2017-10-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 850 mg Oral
Subject plazomicin Small molecule 15 mg/kg Intravenous

Indications

No indication recorded.